Literature DB >> 34202253

Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment.

Francesco Fiz1, Guido Costa2, Nicolò Gennaro3, Ludovico la Bella4, Alexandra Boichuk4, Martina Sollini1,4, Letterio S Politi3,4, Luca Balzarini3, Guido Torzilli2,4, Arturo Chiti1,4, Luca Viganò2,4.   

Abstract

The impact of the contrast medium on the radiomic textural features (TF) extracted from the CT scan is unclear. We investigated the modification of TFs of colorectal liver metastases (CLM), peritumoral tissue, and liver parenchyma. One hundred and sixty-two patients with 409 CLMs undergoing resection (2017-2020) into a single institution were considered. We analyzed the following volumes of interest (VOIs): The CLM (Tumor-VOI); a 5-mm parenchyma rim around the CLM (Margin-VOI); and a 2-mL sample of parenchyma distant from CLM (Liver-VOI). Forty-five TFs were extracted from each VOI (LIFEx®®). Contrast enhancement affected most TFs of the Tumor-VOI (71%) and Margin-VOI (62%), and part of those of the Liver-VOI (44%, p = 0.010). After contrast administration, entropy increased and energy decreased in the Tumor-VOI (0.93 ± 0.10 vs. 0.85 ± 0.14 in pre-contrast; 0.14 ± 0.03 vs. 0.18 ± 0.04, p < 0.001) and Margin-VOI (0.89 ± 0.11 vs. 0.85 ± 0.12; 0.16 ± 0.04 vs. 0.18 ± 0.04, p < 0.001), while remaining stable in the Liver-VOI. Comparing the VOIs, pre-contrast Tumor and Margin-VOI had similar entropy and energy (0.85/0.18 for both), while Liver-VOI had lower values (0.76/0.21, p < 0.001). In the portal phase, a gradient was observed (entropy: Tumor > Margin > Liver; energy: Tumor < Margin < Liver, p < 0.001). Contrast enhancement affected TFs of CLM, while it did not modify entropy and energy of parenchyma. TFs of the peritumoral tissue had modifications similar to the Tumor-VOI despite its radiological aspect being equal to non-tumoral parenchyma.

Entities:  

Keywords:  colorectal liver metastases; computed tomography; contrast medium; radiomics; texture analysis

Year:  2021        PMID: 34202253     DOI: 10.3390/diagnostics11071162

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  33 in total

1.  BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.

Authors:  J-B Bachet; N Moreno-Lopez; L Vigano; U Marchese; M Gelli; L Raoux; S Truant; C Laurent; A Herrero; B Le Roy; S Deguelte Lardiere; G Passot; V Hautefeuille; C De La Fouchardiere; P Artru; T Ameto; J Y Mabrut; L Schwarz; B Rousseau; C Lepère; R Coriat; A Brouquet; A Sa Cunha; S Benoist
Journal:  Br J Surg       Date:  2019-06-10       Impact factor: 6.939

2.  Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.

Authors:  Luca Vigano; Cristiana Soldani; Barbara Franceschini; Matteo Cimino; Ana Lleo; Matteo Donadon; Massimo Roncalli; Alessio Aghemo; Luca Di Tommaso; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

Review 3.  Radiomics and radiogenomics in lung cancer: A review for the clinician.

Authors:  Rajat Thawani; Michael McLane; Niha Beig; Soumya Ghose; Prateek Prasanna; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Lung Cancer       Date:  2017-11-08       Impact factor: 5.705

4.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

5.  CT reconstruction algorithms affect histogram and texture analysis: evidence for liver parenchyma, focal solid liver lesions, and renal cysts.

Authors:  Su Joa Ahn; Jung Hoon Kim; Sang Min Lee; Sang Joon Park; Joon Koo Han
Journal:  Eur Radiol       Date:  2018-11-19       Impact factor: 5.315

6.  Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

Authors:  Laurent Dercle; Lin Lu; Lawrence H Schwartz; Min Qian; Sabine Tejpar; Peter Eggleton; Binsheng Zhao; Hubert Piessevaux
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

7.  ComBat harmonization for radiomic features in independent phantom and lung cancer patient computed tomography datasets.

Authors:  R N Mahon; M Ghita; G D Hugo; E Weiss
Journal:  Phys Med Biol       Date:  2020-01-13       Impact factor: 3.609

8.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

9.  Hepatic entropy and uniformity: additional parameters that can potentially increase the effectiveness of contrast enhancement during abdominal CT.

Authors:  B Ganeshan; K A Miles; R C D Young; C R Chatwin
Journal:  Clin Radiol       Date:  2007-05-23       Impact factor: 2.350

10.  Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.

Authors:  He-Yue Liang; Ya-Qin Huang; Zhao-Xia Yang; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

View more
  3 in total

Review 1.  Radiomics of Biliary Tumors: A Systematic Review of Current Evidence.

Authors:  Francesco Fiz; Visala S Jayakody Arachchige; Matteo Gionso; Ilaria Pecorella; Apoorva Selvam; Dakota Russell Wheeler; Martina Sollini; Luca Viganò
Journal:  Diagnostics (Basel)       Date:  2022-03-28

2.  Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

Authors:  Lei Ye; Yuntian Chen; Hui Xu; Zhaoxiang Wang; Haixia Li; Jin Qi; Jing Wang; Jin Yao; Jiaming Liu; Bin Song
Journal:  Front Cell Dev Biol       Date:  2022-02-25

3.  AX-Unet: A Deep Learning Framework for Image Segmentation to Assist Pancreatic Tumor Diagnosis.

Authors:  Minqiang Yang; Yuhong Zhang; Haoning Chen; Wei Wang; Haixu Ni; Xinlong Chen; Zhuoheng Li; Chengsheng Mao
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.